Trial Profile
A Phase I/II Clinical Trial Assessing Safety and Efficacy of Estetrol (E4) in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Estetrol (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Acronyms ABCE4
- Sponsors Pantarhei Oncology
- 16 Jun 2021 Status changed from active, no longer recruiting to completed.
- 14 Dec 2019 Results presented at the 42nd Annual San Antonio Breast Cancer Symposium
- 19 Nov 2019 Planned End Date changed from 1 May 2019 to 31 Dec 2019.